Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB)
February 07, 2023 01:45 ET
|
Bernstein Liebhard LLP
Did you lose money on investments in Y-mAbs Therapeutics? If so, please visit Y-mAbs Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Joseph R. Seidman, Jr. at (877)...
DEADLINE ALERT for LUV, GWH, BVS, and YMAB: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
February 02, 2023 12:11 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB)
January 31, 2023 01:45 ET
|
Bernstein Liebhard LLP
Did you lose money on investments in Y-mAbs Therapeutics? If so, please visit Y-mAbs Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...
DEADLINE ALERT for YMAB, FATE, and SHC: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
January 27, 2023 14:33 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Jan. 27, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB)
January 26, 2023 01:45 ET
|
Bernstein Liebhard LLP
Did you lose money on investments in Y-mAbs Therapeutics? If so, please visit Y-mAbs Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...
SHAREHOLDER ALERT: Barrack, Rodos & Bacine Encourages Y-mAbs Therapeutics Inc. (YMAB) Shareholders to Contact the Firm About a Recently Filed Securities Class Action Lawsuit
January 23, 2023 09:30 ET
|
Barrack Rodos & Bacine
PHILADELPHIA, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Barrack, Rodos & Bacine notifies investors that a securities class action lawsuit has been filed on behalf of purchasers of the common stock of...
Y-MABS THERAPEUTICS, INC. (NASDAQ: YMAB) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB)
January 20, 2023 16:00 ET
|
Bernstein Liebhard LLP
Did you lose money on investments in Y-mAbs Therapeutics? If so, please visit Y-mAbs Therapeutics, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212)...
DEADLINE ALERT for LUV, ESS, and YMAB: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
January 20, 2023 13:01 ET
|
The Law Offices of Frank R. Cruz
LOS ANGELES, Jan. 20, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
Bragar Eagel & Squire, P.C. Is Investigating Evolus, Lizhi, Iovance Biotherapeutics, and Y-mAbs Therapeutics and Encourages Investors to Contact the Firm
October 09, 2020 21:00 ET
|
Bragar Eagel & Squire
NEW YORK, Oct. 09, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating potential claims against on behalf of investors of Evolus,...